Cipla USA
NJ - WarrenBiotechnology
Focus: Cipla USA is a subsidiary of India-based Cipla, specializing in generic pharmaceuticals, active pharmaceutical ingredients (APIs), and formulations across respiratory, infectious diseases, and oncology markets. The company operates as a mid-sized generics player with a diversified therapeutic portfolio.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Cipla USA
AI assessmentNot HiringNo open roles listed right now. Follow Cipla USA to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Generic HAART Triomune
Declining
Post-LOE
Established generic HIV combination therapy with phase 4 status; represents core Cipla strength in infectious disease generics but faces mature market dynamics.
Insulin Lispro-aabc
Help build intelligence for Cipla USA
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.